fibrinogen has been researched along with 2019 Novel Coronavirus Disease in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 145 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çakırca, G; Çakırca, TD; Portakal, RD; Torun, A | 1 |
| Acevedo, V; Álvarez, P; Aroca, P; Carvajal, C; Cofré, F; Mackenney, J; Montes, V; Poli, C; Soto, V; Tapia, L; Verdugo, P | 1 |
| Chen, M; Lu, H; Tang, S; Yu, W | 1 |
| An, H; Chen, C; Huang, C; Jin, S; Li, M; Li, S; Li, T; Li, X; Xu, Z; Ying, B; Zhang, J; Zhou, T | 1 |
| Bocci, M; Edén, A; Englund, E; Gisslén, M; Möller, C; Oudenaarden, C; Pietras, K; Sàenz-Sardà, X; Simrén, J; Sjölund, J; Zetterberg, H | 1 |
| Helin, TA; Joutsi-Korhonen, L; Koskinen, M; Lahtiharju, T; Lassila, R; Lemponen, M | 1 |
| Cabrera-Garcia, D; Harrison, NL; Houck, PJ; Miltiades, A; Monteleone, M; Roh, D; Wagener, G | 1 |
| AbdulKarim, F; Ahmad, F; Al-Tamimi, AO; Ansari, AW; Elhassan, M; Halwani, R; Jayakumar, MN; Kannan, M; Yusuf, AM | 1 |
| Abdullayev, R; Bilgili, B; Cinel, I; Gul, F; Seven, S | 1 |
| An, H; Chen, C; Hu, Y; Jin, S; Li, M; Li, T; Wang, Q; Ying, B; Zhang, J | 1 |
| Bargotya, M; Bhattar, S; Dogra, V; Ganju, L; Garg, I; Ghosh, N; Gupta, U; Hembrom, AA; Hussain, J; Jain, S; Kumar, V; Srivastava, S; Varshney, R | 1 |
| Boccatonda, A; Bucci, M; Cipollone, F; Cocco, G; D'Ardes, D; Fabiani, S; Guagnano, MT; Rossi, I; Schiavone, C | 1 |
| Antonucci, F; Di Carlo, D; Falcone, M | 1 |
| Chen, X; Deng, G; Duan, Z; Jin, L; Lai, R; Li, Y; Liu, M; Luan, N; Meng, P; Tan, Z; Wang, J; Zhang, J; Zhang, Z; Zhao, H | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Batiha, GE; El-Bouseary, MM; Sonbol, FI | 1 |
| DeSancho, MT; Dev, H; Lane, EG; Margolis, DJ; Prince, MR | 1 |
| Aktar, I; Genc, S; Kaytaz, M; Medetalibeyoglu, A; Omer, B; Oncul, O; Senkal, N; Tukek, T | 1 |
| Akkaya, E; Genc, S; Gumus, SN; Issever, H; Kaytaz, M; Omer, B | 1 |
| Bulgarelli, I; Calcagno, N; Colombrita, C; Maranzano, A; Milone, I; Parati, G; Perego, GB; Peverelli, S; Ratti, A; Silani, V; Ticozzi, N; Torresani, E; Verde, F | 1 |
| Harris, S; Hidayat, R; Kurniawan, M; Mesiano, T; Rasyid, A; Riyanto, DL; Wiyarta, E | 1 |
| Chen, WC; Chen, YM; Feng, JY; Huang, JR; Shen, HC; Sun, CY; Yang, KY | 1 |
| Abderraouf, O; Ajmi, C; Amene, BB; Amina, B; Elaa, A; Haifa, M; Houyem, SL; Syrine, C; Walid, N | 1 |
| Can, M; Guven, B; Tekin, A | 1 |
| Baskina, OS; Beregovykh, VV; Ivanov, SV; Korotchenko, SA; Lapshin, RD; Markin, SS; Mukhina, IV; Semenov, AM; Semenov, MP | 1 |
| Frydman, GH; Gallastegi, AD; Jamali, S; Javadi, E; Karniadakis, GE; Li, H | 1 |
| Flick, MJ; Kangro, K; Wolberg, AS | 1 |
| Benítez-López, GA; Bhattar, K; Flowers, TC; Hilliard, J; Iqbal, K; Khalil, K; Madekwe, CC; Moreno Cortes, GA; Nieto-Salazar, MA; Oberoi, S; Rathore, SS; Velasquez-Botero, F | 1 |
| Artime, A; Basterrechea, H; Díaz-Salazar, S; Fierro, P; Hernández, JL; Maamar, M; Navas, R; Olmos, JM; Pariente, E; Petitta, B; Pini, S; Ramos, C; Sainz-Maza, L | 1 |
| Chowdary, P; Davenport, A; Gandhi, T; Riddell, A; Sudusinghe, D | 1 |
| Brown, A; Moiseiwitsch, N; Sniecinski, R; Szlam, F; Zwennes, N | 1 |
| Cunningham, RM; Johnson Moore, KL; Moore, JS | 1 |
| Kell, DB; Kruger, A; Laubscher, GJ; Pretorius, E; Turner, S; Venter, C; Vlok, M | 1 |
| Baus, C; Jefferson, M; McClure, A; Patel, S; Recker, A; Teran, P; Wittler, R | 1 |
| Bhargavan, B; Kanmogne, GD | 1 |
| Celikkol, A; Dogan, M; Erdal, B; Guzel, EC; Yilmaz, A | 1 |
| Connors, JM; Iba, T | 1 |
| Andrianova, IA; Ataullakhanov, FI; Evtugina, NG; Khabirova, AI; Litvinov, RI; Peshkova, AD; Rumyantsev, AG; Safiullina, SI; Sannikova, SS; Tarasova, GR | 1 |
| Gémes, B; Horvath, R; Székács, A; Székács, I; Takács, E | 1 |
| Basso, M; Buonsenso, D; De Candia, E; De Cristofaro, R; De Rose, C; Di Gennaro, L; Ferretti, MA; Lancellotti, S; Lazzareschi, I; Mariani, F; Morello, R; Munblit, D; Sigfrid, L; Sorrentino, S; Valentini, P | 1 |
| Altintop, SE; Cihangiroglu, M; Gozukara, B; Gozukara, M; Milletli-Sezgin, F; Onarer, P; Unalan-Altintop, T; Zengin, E | 1 |
| Cambier, M; Cavalier, E; Darcis, G; Frix, AN; Gofflot, S; Guiot, J; Henket, M; Louis, R; Misset, B; Moutschen, M; Njock, MS; Peired, A; Rousseau, AF; Struman, I; Thys, M; Tomasetti, S | 1 |
| Jaswal, A; Kapoor, Y; Khurana, S; Kumar, V; Rajput, S; Saini, A; Saini, D; Saini, S; Singh, J; Thakur, CJ | 1 |
| Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A | 1 |
| Abenavoli, L; Falalyeyeva, T; Halenova, T; Karbovskyy, V; Krenytska, D; Liubenko, D; Ostapchenko, L; Rachkovska, A; Raksha, N; Savchuk, O; Vovk, T | 1 |
| Ayata, R; Esaki, Y; Fujita, M; Harada, K; Kaneda, K; Koga, Y; Shin, M; Tsuruta, R; Yagi, T | 1 |
| Amini, A; Arabzadeh, E; Avazpour, S; Shirvani, H | 1 |
| Emet, A; Konyaoglu, H; Kose, M; Oyaci, Y; Pehlivan, S; Sayin, GY; Senkal, N | 1 |
| Cai, YL; Chen, SQ; Liang, SS; Lin, YL; Wang, QW; Wu, PL; Zhang, YF; Zhuang, XB | 1 |
| Borzan, A; Borzan, V; Dmitrović, B; Frič, VO; Kiš, I; Roksandić-Križan, I | 1 |
| Ahn, J; Albizua, I; Anderson, EJ; Arthur, CM; Bosinger, SE; Bowen, T; Chahroudi, A; Chandler, JD; Druzak, S; Fibben, KS; Geller, R; Iffrig, E; Ivanova, AA; Kim, SO; Kulpa, DA; Lam, WA; Liu, X; Maier, CL; Maner-Smith, K; Mosunjac, M; Ortlund, EA; Paiardini, M; Roback, JD; Roberts, AM; Roberts, BR; Rostad, CA; Sakurai, Y; Schneider, F; Silvestri, G; Stowell, SR; Verkerke, HP; Wong, AKH; Zhang, T | 1 |
| Afşin, DE; Aksakal, A; Baygutalp, NK; Kerget, B; Kiliç, AF | 1 |
| Apsalikov, B; Aukenov, N; Kadyrova, I; Kazymov, M; Massabayeva, M; Mussazhanova, Z; Shaimardanov, N; Shakhanova, A; Yessenbayeva, A | 1 |
| Küçük, S; Yilmaz, E | 1 |
| Baralić, M; Bontić, A; Brković, V; Dobrijević, Z; Gligorijević, N; Katrlík, J; Laušević, M; Miljuš, G; Nedić, O; Nikolić, J; Pavlović, J; Pažitná, L; Penezić, A; Robajac, D; Šunderić, M | 1 |
| Aminpour, M; Santin, AD; Scheim, DE; Tavernini, S; Tuszynski, JA; Vottero, P | 1 |
| Keskin, H; Koçak, H; Korkmaz, P; Mıstanoglu Ozatag, D | 1 |
| Kell, DB; Pretorius, E | 1 |
| Arruda, E; Castro, IA; Cunha, FQ; Cunha, TM; da Cunha, LD; de Lima, MHF; Filho, JA; Louzada-Junior, P; Machado, CC; Nascimento, DC; Oliveira, RDR; Pontelli, MC; Rodrigues, TS; Silva, CMS; Toller-Kawahisa, JE; Veras, FP; Zamboni, DS | 1 |
| Jin, L; Lei, L; Xu, X; Zhang, B; Zhao, Y; Zhu, J | 1 |
| Bielosludtseva, K; Konopkina, L; Krykhitna, M; Pertseva, T | 1 |
| Abdullah, M; Gathmyr, D; Harahap, AT; Harimurti, K; Irawan, C; Lubis, AM; Nainggolan, L; Shatri, H; Susilo, A | 1 |
| Han, H; Li, J; Liu, F; Liu, R; Liu, XH; Wu, KL; Yang, L; Zhu, CL | 1 |
| Gao, Y; Han, M; Li, T; Li, X; Liu, Y; Wang, L; Wang, X; Wu, D; Xu, Y; Zhu, Y | 1 |
| Li, CX; Luo, F; Wu, B; Zhang, N | 1 |
| Beun, R; Huisman, A; Kusadasi, N; Sikma, M; Westerink, J | 1 |
| Boscolo, A; Campello, E; Cerruti, L; Navalesi, P; Poletto, F; Simioni, P; Spiezia, L; Tiberio, I | 1 |
| Caneva, L; Civardi, L; Mojoli, F; Mongodi, S; Tavazzi, G | 1 |
| Barker, NA; Maier, CL; Sniecinski, RM | 1 |
| Benner, P; Betoule, A; Foucher, S; Gasperini, G; Martinet, C; Muller, P; Renard, A | 1 |
| Levi, M; Thachil, J | 1 |
| Gogos, C; Lagadinou, M; Marangos, M; Salomou, EE; Velissaris, D; Zareifopoulos, N | 1 |
| Chow, JH; Galvagno, S; Grazioli, A; Herr, D; Madathil, R; Mazzeffi, M; Menaker, J; Menne, A; Rabin, J; Scalea, T; Tabatabai, A; Tanaka, K | 1 |
| Iba, T; Levi, M; Levy, JH; Thachil, J | 1 |
| Alberio, L; Artru, F; Casini, A; Chtioui, H; Fraga, M; Moradpour, D; Neerman-Arbez, M; Romailler, E; Schneider, A; Sempoux, C; Tschopp, J | 1 |
| Thachil, J | 1 |
| Fu, X; Li, H; Liu, W; Long, H; Nie, L; Ren, H; Wang, Q; Wu, Q; Xiang, X; Zhang, X | 1 |
| Alfonso, F; Antuña, P; Cuesta, J; Del Val, D; Rivero, F | 1 |
| Danaee, A; Doyle, AJ; Furtado, CI; Maggs, T; Miller, S; Retter, A; Robinson, SE | 1 |
| Ahmed, S; Gasparyan, AY; Zimba, O | 1 |
| Di, Z; Fu, J; Huang, C; Kong, J; Shi, B; Sun, H; Wang, T; Wu, D; Yang, Y; Yu, X; Yuan, D | 1 |
| Arter, WE; Chevassut, T; Eziefula, AC; Ladikou, EE; Milne, KM; Philips, B; Ramasamy, R; Saad, R; Sivaloganathan, H; Stoneham, SM | 1 |
| Çınar, T; Hayıroğlu, Mİ; Tekkeşin, Aİ | 1 |
| Dong, Y; Guo, W; Li, Y; Ma, X; Shi, D; Song, L; Xu, M; Zhang, X | 1 |
| Chen, H; He, C; He, H; Lin, C; Lin, J; Lin, K; Shi, S; Yan, H; Zhang, S | 1 |
| Baron, RM; Chen, EC; Cheng, V; Cho, MH; Connell, NT; Connors, JM; Fredenburgh, LE; Moll, M; Sylvester, KW; Woolley, AE; Zon, RL | 1 |
| Erkan, D; James, JA; Merrill, JT; Winakur, J | 1 |
| Sangith, N | 1 |
| Bréchot, N; Chommeloux, J; Combes, A; Desnos, C; Edouard Luyt, C; Frere, C; Hékimian, G; Lebreton, G; Lejeune, M; Martin-Toutain, I; Masi, P; Nieszkowska, A; Pineton De Chambrun, M; Schmidt, M | 1 |
| Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M | 1 |
| Cheng, L; Guan, H; He, M; Hu, C; Huang, K; Ji, Q; Ke, Z; Keerman, M; Leng, L; Liu, B; Meng, K; Peng, Y; Wang, X; Wu, T; Zeng, Q; Zhu, R | 1 |
| Badley, AD; Barnathan, ES; Gores, GJ; Halamka, J; Houghton, DE; Khan, N; Loscalzo, L; Makimura, H; Morice, WG; Murugadoss, K; O'Horo, JC; Pawlowski, C; Pruthi, RK; Puranik, A; Soundararajan, V; Venkatakrishnan, AJ; Wagner, T; Williams, AW | 1 |
| Brustman, L; Ganz, E; Khalil, S; Kinsey, KE | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Guo, L; Wang, L; Wang, X; Xia, X; Yao, H; Zhang, W; Zheng, J | 1 |
| Altmayer, V; Cao, A; Demeret, S; Gallo, A; Le Guennec, L; Marois, C; Rohaut, B; Saheb, S; Weiss, N | 1 |
| Battinelli, EM; Chen, EC; Connors, JM; Zon, RL | 1 |
| Benoit, JL; Benoit, SW; Favaloro, EJ; Henry, BM; Hoehn, J; Lippi, G | 1 |
| Chow, JH; Mazzeffi, MA; Tanaka, K | 1 |
| Besser, M; Bridgeman, C; Cox-Morton, S; Duff, E; Edwards, T; Hayman, M; Kirk, M; MacDonald, S; Mahajan, S; Moore, C; Sharp, M; Thomas, W; White, D; Williams, R | 1 |
| Sholzberg, M | 1 |
| Asher, E; Ben-Chetrit, E; Helviz, Y; Tvito, A; Zimmerman, FS | 1 |
| Demeester, S; Demuyser, T; Depreter, B; Fauconnier, C; Heestermans, R; Jochmans, K; Orlando, C | 1 |
| Harada, S; Ikeda, M; Jubishi, D; Kanno, Y; Kurano, M; Moriya, K; Okamoto, K; Okugawa, S; Osawa, I; Otani, A; Shinohara, T; Wakimoto, Y; Yamashita, M; Yatomi, Y | 1 |
| Chen, L; Li, D; Liu, Q; Lu, S; Wang, Y; Yan, H; Yan, J; Yan, X | 1 |
| Bonnin, P; Chousterman, BG; Delrue, M; Deye, N; Ketfi, C; Malissin, I; Mebazaa, A; Mégarbane, B; Neuwirth, M; Siguret, V; Stépanian, A; Voicu, S | 1 |
| Shen, XH; Tang, PJ; Wang, Y; Wu, MY; Xu, JC; Yao, L; Ye, ZJ; Yu, X; Zhang, JP | 1 |
| Alberici, A; Baldelli, E; Benini, M; Benussi, A; Bonacina, S; Borroni, B; Brambilla, L; Caratozzolo, S; Cortinovis, M; Costa, A; Cotti Piccinelli, S; Cottini, E; Cristillo, V; Delrio, I; Ferrari, S; Filosto, M; Gamba, M; Gasparotti, R; Gazzina, S; Gilberti, N; Gipponi, S; Giunta, M; Imarisio, A; Leonardi, M; Liberini, P; Libri, I; Locatelli, M; Magoni, M; Mariotto, S; Masciocchi, S; Padovani, A; Paolillo, C; Pezzini, A; Pilotto, A; Poli, L; Premi, E; Rao, R; Risi, B; Rozzini, L; Scalvini, A; Schiano, F; Vergani, V; Volonghi, I; Zanusso, G; Zoppi, N | 1 |
| A'yun, MQ; Maghfirah, I; Mulia, EP; Nugroho, J; Rachmi, DA; Septianda, I; Wardhana, A | 1 |
| Cai, L; Ding, Y; Kou, G; Liu, L; Liu, W; Tang, S; Wang, S; Wu, W; Xiong, Z; Zheng, S; Zheng, Y | 1 |
| Hirouchi, T; Kamachi, K; Morikawa, M; Ota, S; Sasaki, O; Sato, T; Shinada, K; Shinkai, M; Shinoda, M; Yoshida, Y | 1 |
| Bhansali, A; Khare, N; Malhotra, P; Puri, GD; Rastogi, A; Sachdeva, N; Suri, V; Yaddanapudi, N | 1 |
| Bethune, D; Chan, JD; Cheng, GS; Dhanireddy, S; Green, M; Hill, JA; Huang, J; Jain, R; Johnston, C; Leisenring, WM; Menon, MP; Nina Kim, H; Turtle, C; Wurfel, MM; Xie, H | 1 |
| Fu, WJ; He, M; Huang, XZ; Kang, CM; Ke, PF; Liang, EY; Shen, Y; Song, L; Wang, HM; Xiong, YJ | 1 |
| Eljilany, I; Elzouki, AN | 1 |
| Bieber, A; Brikman, S; Dori, G | 1 |
| Sharma, M; Surani, S | 1 |
| Hayakawa, M; Ieko, M; Komiyama, Y; Kumano, O; Naito, S; Ohmura, K; Takahashi, N; Yoshida, M | 1 |
| Antonelli, M; Biasucci, DG; Bocci, MG; Carelli, S; Consalvo, LM; Cutuli, SL; De Candia, E; Franceschi, F; Gori, C; Grieco, DL; Maviglia, R; Mercurio, G; Montini, L; Nardi, G; Natalini, D; Pisapia, L; Rosenkranz, R | 1 |
| Andreotti, F; De Cristofaro, R; Lancellotti, S; Liuzzo, G; Pedicino, D; Sacco, M | 1 |
| Antic, D; Bukumiric, Z; Cvetkovic, Z; Fareed, J; Libek, V; Milenkovic, B; Milosevic, I; Mitrovic, M; Pantic, N; Pravdic, Z; Sabljic, N; Savic, N; Suvajdzic, N; Virijevic, M; Vucinic, V; Zivkovic Dakic, A | 1 |
| Bade, N; Chandel, A; Khangoora, V; King, CS; Looby, M; Patolia, S | 1 |
| Bazine, M; Cholley, B; Clausse, D; Godier, A; Hamada, SR; Huche, F; Lang, E; Meslin, S | 1 |
| Harada, S; Ikeda, M; Jubishi, D; Kanno, Y; Kurano, M; Moriya, K; Okamoto, K; Okugawa, S; Shimura, T; Yatomi, Y | 1 |
| Adami, G; Benini, C; Bertoldo, E; Bertoldo, F; Fassio, A; Gatti, D; Giannini, S; Giollo, A; Idolazzi, L; Micheletto, C; Orsolini, G; Passeri, G; Rossini, M; Tacconelli, E; Viapiana, O | 1 |
| Huang, Y; Patel, J; Tang, L; Yin, L; Zhao, Y | 1 |
| Isbell, TS; Khatun, M; Ray, R; Ray, RB; Steele, R; Sur, S | 1 |
| Fukuda, Y; Goto, Y; Hirai, K; Homma, T; Ikeda, H; Inoue, H; Kimura, T; Kusumoto, S; Ohta, S; Onitsuka, C; Sagara, H; Sato, Y; Suzuki, S; Tanaka, A; Yamamoto, M | 1 |
| Barrett, NA; Benedetti, G; Breen, KA; Camporota, L; Doyle, AJ; Hunt, BJ; Mak, SM; Retter, A; Sanderson, B; Zhang, J | 1 |
| Abe, O; Amano, Y; Gonoi, W; Harada, S; Inui, S; Iwabu, M; Kage, H; Kurokawa, R; Moriya, K; Morizaki, Y; Nagase, T; Nakai, Y; Okamoto, K; Tanaka, G | 1 |
| Marco, A; Marco, P | 1 |
| Bart, Y; Friedrich, L; Levin, G; Maixner, N; Meyer, R; Tsur, A; Yinon, Y | 1 |
| Ayranci, MK; Girişgin, AS; Koçak, S; Küçükceran, K | 1 |
| Deveci, F; Kuluöztürk, M; Öner, Ö; Turgut, T | 1 |
| Ball, P; Blann, A; Marwah, M; Marwah, S; Morrissey, H; Wandroo, FA | 1 |
| Alkan, M; Altunok, ES; Börü, A; Demirkol, MA; Demirok, B; Gürsoy, B; Kamat, S; Satıcı, C; Sürmeli, CD | 1 |
| Alessio, MG; Bonaffini, PA; Chun, HJ; Fernandez-Hernando, C; Hwa, J; Iwakiri, Y; Kawaguchi, N; Kondo, R; Lee, AI; Licini, L; McConnell, MJ; Pine, AB; Previtali, G; Price, C; Qing, H; Seghezzi, M; Sironi, S; Sonzogni, A; Strazzabosco, M; Sun, Z; Utsumi, T; Valle, C; Wang, A; Zhang, X | 1 |
| Chen, H; Gao, R; Qin, L; Wu, S; Xu, W; Zhang, X | 1 |
| Bergonzini, G; Busani, S; Castellano, S; Cossarizza, A; De Biasi, S; Gibellini, L; Girardis, M; Guaraldi, G; Luppi, M; Lusenti, B; Manfredini, R; Milić, J; Mussini, C; Nasillo, V; Ottomano, AM; Paolini, A; Riva, G; Tagliafico, E; Trenti, T | 1 |
| Costa, P; Dufrost, V; Foret, T; Lacolley, P; Lefevre, B; Regnault, V; Salomon Du Mont, L; Wahl, D; Zuily, S | 1 |
| Faisal, HKP; Juliani, T; Sugihen, TTG; Taufik, FF; Yunus, F | 1 |
| Fukuda, T; Ichikawa, J; Ishikawa, M; Komori, M; Okazaki, R; Ono, T | 1 |
| Devreese, KMJ | 1 |
| Grobbelaar, LM; Kell, DB; Laubscher, GJ; Lourens, PJ; Ngoepe, M; Pretorius, E; Steenkamp, J; Venter, C; Vlok, M | 1 |
| Bliden, KP; Cho, A; Gurbel, PA; Jerjian, C; Levy, JH; Rapista, N; Tantry, US; Walia, N | 1 |
| Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S | 1 |
23 review(s) available for fibrinogen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
Topics: Blood Coagulation Disorders; COVID-19; Fibrinogen; Humans; Liver Diseases; SARS-CoV-2; Thrombosis | 2022 |
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties.
Topics: COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Immune System Diseases; Immunoglobulins; Post-Acute COVID-19 Syndrome; Prospective Studies; Vaccination; Vaccines | 2023 |
Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.
Topics: COVID-19; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pandemics; SARS-CoV-2 | 2022 |
Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: A meta-analysis.
Topics: Biomarkers; C-Reactive Protein; COVID-19; Fibrinogen; Humans; Prognosis | 2022 |
Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
Topics: Aged; Aged, 80 and over; Antithrombins; COVID-19; Factor VIII; Female; Fibrinogen; Heparin; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Thrombosis | 2023 |
Coagulopathy during COVID-19 infection: a brief review.
Topics: Blood Coagulation Disorders; COVID-19; Fibrinogen; Humans; Pandemics; SARS-CoV-2 | 2023 |
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
Topics: COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Neoplasms; Pandemics; Pharmaceutical Preparations; Purpura, Thrombocytopenic, Idiopathic; SARS-CoV-2; Syndrome; Thrombocytopenia; Thrombosis; Vaccines | 2022 |
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Disseminated Intravascular Coagulation; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Mice; Pandemics; Pneumonia, Viral; Prothrombin Time; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Thrombotic Microangiopathies | 2020 |
Coagulopathy in COVID-19.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Inflammation; Lung; Lymphocytes; Partial Thromboplastin Time; Protease Inhibitors; Prothrombin Time; Sepsis; Thrombosis | 2020 |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Betacoronavirus; Blood Platelets; Blood Viscosity; Coronavirus Infections; COVID-19; Endothelium, Vascular; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Pandemics; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Aggregation Inhibitors; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2020 |
Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
Topics: Anticoagulants; Betacoronavirus; Biomarkers; Blood Coagulation Disorders; Coronavirus; Coronavirus Infections; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 and coagulation dysfunction in adults: A systematic review and meta-analysis.
Topics: Blood Coagulation Disorders; Blood Platelets; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospitalization; Humans; Partial Thromboplastin Time; Prognosis; Risk Factors; Severity of Illness Index | 2021 |
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Topics: Anticoagulants; Antiviral Agents; Betacoronavirus; Complement System Proteins; Coronavirus Infections; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Pandemics; Plasma Exchange; Platelet Count; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Thrombosis; Thrombotic Microangiopathies | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Topics: Anticoagulants; Biomarkers; Blood Coagulation Disorders; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; SARS-CoV-2; Thromboembolism; Thrombosis | 2020 |
COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management.
Topics: Anticoagulants; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Correlation of Data; COVID-19; Endothelium, Vascular; Extracorporeal Membrane Oxygenation; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Monitoring, Physiologic; Respiration, Artificial; Thrombelastography; Thrombophilia | 2021 |
Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: A meta-analysis.
Topics: COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pandemics; Patient Outcome Assessment; SARS-CoV-2 | 2021 |
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Topics: Anticoagulants; Biomarkers; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Incidence; Inflammation Mediators; Interleukin-6; Prevalence; Prognosis; Risk Assessment; Risk Factors; Venous Thromboembolism | 2020 |
The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
Topics: Aspartate Aminotransferases; C-Reactive Protein; COVID-19; Cytokine Release Syndrome; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Lymphopenia; Pancytopenia; Patient Acuity; Pneumonia; SARS-CoV-2 | 2020 |
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19.
Topics: Anticoagulants; Computed Tomography Angiography; COVID-19; Disease Management; Disseminated Intravascular Coagulation; Echocardiography; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prothrombin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombophilia; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Ventilation-Perfusion Scan | 2020 |
The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Topics: Adolescent; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; COVID-19; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Infant, Newborn; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Count; Lymphocytes; Neutrophils; Platelet Count; Procalcitonin; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Young Adult | 2021 |
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Topics: Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; beta 2-Glycoprotein I; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis | 2021 |
COVID-19-related laboratory coagulation findings.
Topics: Antibodies, Antiphospholipid; Biomarkers; Blood Coagulation Factors; Blood Coagulation Tests; COVID-19; Disseminated Intravascular Coagulation; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin, Low-Molecular-Weight; Humans; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; SARS-CoV-2; Thrombelastography; Thrombin; Thrombophilia | 2021 |
3 trial(s) available for fibrinogen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The evaluation of the relationship between COVID-19 and autoimmune responses with a cross-sectional trial using medical records.
Topics: Adult; Aged; Autoimmunity; C-Reactive Protein; COVID-19; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Medical Records; Middle Aged; Retrospective Studies; SARS-CoV-2 | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
Topics: Adult; Biomarkers; C-Reactive Protein; Cholecalciferol; COVID-19; COVID-19 Drug Treatment; Dietary Supplements; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Procalcitonin; RNA, Viral; SARS-CoV-2; Vitamin D; Vitamin D Deficiency | 2022 |
120 other study(ies) available for fibrinogen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.
Topics: Albumins; C-Reactive Protein; COVID-19; Fibrinogen; Humans; Lymphocytes; Neutrophils; Retrospective Studies; SARS-CoV-2 | 2021 |
Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2.
Topics: Biomarkers; C-Reactive Protein; Child; Clinical Deterioration; COVID-19; Critical Illness; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukocytes; Male; Neutrophils; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombocytopenia | 2021 |
Association of coagulation disturbances with severity of COVID-19: a longitudinal study.
Topics: Adult; Aged; Blood Coagulation; COVID-19; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Partial Thromboplastin Time; Severity of Illness Index; Thrombophilia | 2021 |
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; China; COVID-19; Disease Progression; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Inflammation; Male; Middle Aged; Prothrombin Time; SARS-CoV-2 | 2021 |
Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood-Brain Barrier; Brain; Case-Control Studies; COVID-19; Encephalitis, Viral; Fibrinogen; Humans; Immunohistochemistry; Mice; Pericytes; Receptor, Platelet-Derived Growth Factor beta | 2021 |
Anaemia and enhancement of coagulation are associated with severe COVID-19 infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antithrombins; Big Data; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Finland; Humans; Intensive Care Units; Male; Middle Aged; Platelet Count; Retrospective Studies; Young Adult | 2021 |
Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients.
Topics: COVID-19; Critical Illness; Fibrinogen; Fibrinolysis; Humans; SARS-CoV-2; Tissue Plasminogen Activator | 2022 |
SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.
Topics: Biomarkers; COVID-19; Fibrinogen; Humans; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; SARS-CoV-2; Tissue Plasminogen Activator | 2022 |
Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study.
Topics: Adsorption; Case-Control Studies; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies | 2022 |
Inflammation/Coagulopathy/Immunology Responsive Index Predicts Poor COVID-19 Prognosis.
Topics: Blood Coagulation Disorders; C-Reactive Protein; CD8-Positive T-Lymphocytes; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Retrospective Studies; ROC Curve | 2022 |
Implications of COVID-19 on Thrombotic Profile of Severely Affected Patients.
Topics: Anticoagulants; COVID-19; Fibrinogen; Humans; Retrospective Studies; SARS-CoV-2; Thrombosis | 2022 |
Evaluation of a potential prognostic parameter for the inflammatory status in COVID-19 patients: The inflammatory protein ratio.
Topics: Albumins; COVID-19; Fibrinogen; Humans; Prognosis; RNA, Viral; SARS-CoV-2 | 2022 |
Role of LL-37 in thrombotic complications in patients with COVID-19.
Topics: Antimicrobial Cationic Peptides; Blood Coagulation Factors; Cathelicidins; COVID-19; Fibrinogen; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thrombosis | 2022 |
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.
Topics: Anticoagulants; COVID-19; COVID-19 Drug Treatment; Fibrinogen; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Venous Thromboembolism | 2022 |
Would Tracking Coagulation Together with Inflamation Markers be a Prospect for COVID-19 Disease Prognosis?
Topics: Biomarkers; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Partial Thromboplastin Time; Prognosis; Prothrombin Time; SARS-CoV-2 | 2022 |
IgG-RBD Response Due to Inactivated SARS-CoV-2 Vaccine: Alteration in D-Dimer and Fibrinogen Concentrations, Association with Comorbidities and Adverse Effects.
Topics: COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Immunoglobulin G; Receptors, IgG; SARS-CoV-2; Viral Vaccines | 2022 |
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
Topics: Biomarkers; C-Reactive Protein; COVID-19; Creatinine; Fibrinogen; Humans; Intermediate Filaments; Neurofilament Proteins; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Association of coagulation factors profile with clinical outcome in patient with COVID-19 and acute stroke: A second wave cohort study.
Topics: Adult; Cohort Studies; COVID-19; Fibrinogen; Humans; Prothrombin Time; Retrospective Studies; SARS-CoV-2; Stroke | 2022 |
COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Topics: COVID-19; Fibrinogen; Hospital Mortality; Humans; Intensive Care Units; Pulmonary Aspergillosis; Retrospective Studies; SARS-CoV-2; Virus Shedding | 2022 |
Assessment of Coagulation Profiles by Rotational Thromboelastometry in COVID 19 Patients.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Fibrinogen; Humans; SARS-CoV-2; Thrombelastography; Thrombophilia | 2022 |
Comparison of Fibrinogen Concentrations Determined by the Clauss Method with Prothrombin-Derived Measurements on an Automated Coagulometer.
Topics: Blood Coagulation Tests; COVID-19; Fibrinogen; Humans; Prothrombin; Retrospective Studies | 2022 |
Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model.
Topics: Acute Lung Injury; Animals; COVID-19; Disease Models, Animal; Fibrin; Fibrinogen; Lipopolysaccharides; Lung; Metalloendopeptidases; Mice; Rats; Respiratory Distress Syndrome | 2022 |
Circulating cell clusters aggravate the hemorheological abnormalities in COVID-19.
Topics: Blood Viscosity; COVID-19; Fibrinogen; Hemorheology; Humans | 2022 |
Blood group O is associated with post-COVID-19 syndrome in outpatients with a low comorbidity index.
Topics: ABO Blood-Group System; Adult; Albumins; Antibodies, Viral; Biomarkers; Case-Control Studies; Comorbidity; COVID-19; Female; Fibrinogen; Humans; Immunoglobulin G; Male; Middle Aged; Outpatients; Post-Acute COVID-19 Syndrome; Retrospective Studies; SARS-CoV-2 | 2022 |
COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
Topics: COVID-19; Fibrin; Fibrinogen; Fibrinolysis; Hemostatics; Humans; N-Acetylneuraminic Acid; Neuraminidase; Polymerization; SARS-CoV-2; Thrombosis | 2022 |
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.
Topics: alpha-2-Antiplasmin; Biomarkers; C-Reactive Protein; COVID-19; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Humans; Interleukin-6; Plasma Kallikrein; Platelet Factor 4; Post-Acute COVID-19 Syndrome; Proteomics; Thrombosis; von Willebrand Factor | 2022 |
A 14-Year-Old Boy With Neck Pain, Fevers, and Diffuse Erythematous Rash.
Topics: Adolescent; Anti-Bacterial Agents; C-Reactive Protein; Child; COVID-19; Erythema; Exanthema; Ferritins; Fever; Fibrinogen; Humans; Lactate Dehydrogenases; Male; Natriuretic Peptide, Brain; Neck Pain; SARS-CoV-2; Triglycerides | 2022 |
SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Topics: Angiotensin-Converting Enzyme 2; Blood Coagulation Disorders; Cell Communication; COVID-19; Endothelial Cells; Endothelium; Fibrinogen; Humans; Lipoproteins; Lung; Neutrophils; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Sulfhydryl Compounds; Thrombin; Thrombomodulin; Thromboplastin; Thrombosis | 2022 |
A novel combined index of D-dimer, fibrinogen, albumin, and platelet (FDAPR) as mortality predictor of COVID-19.
Topics: Albumins; Biomarkers; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Retrospective Studies; SARS-CoV-2 | 2022 |
[Peculiarities of blood coagulation disorders in patients with COVID-19].
Topics: Anticoagulants; Blood Coagulation Disorders; C-Reactive Protein; COVID-19; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Hemostatics; Heparin, Low-Molecular-Weight; Humans; Inflammation; Interleukins; SARS-CoV-2; Thrombophilia; Thrombosis | 2021 |
Comparative Assessment of the Inhibitory Potential of the Herbicide Glyphosate and Its Structural Analogs on RGD-Specific Integrins Using Enzyme-Linked Immunosorbent Assays.
Topics: COVID-19; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Herbicides; Humans; Integrin alphaVbeta3; Oligopeptides; Polymers; SARS-CoV-2; Vitronectin | 2022 |
Extended coagulation profile of children with Long Covid: a prospective study.
Topics: Adult; Case-Control Studies; Child; COVID-19; COVID-19 Testing; Female; Fibrinogen; Humans; Infant, Newborn; Male; Post-Acute COVID-19 Syndrome; Prospective Studies; SARS-CoV-2; von Willebrand Factor | 2022 |
COVID-19 in elderly: Correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac.
Topics: Aged; Aged, 80 and over; COVID-19; Disease Progression; Fibrinogen; Humans; Middle Aged; SARS-CoV-2; Viral Load | 2022 |
Increased KL-6 levels in moderate to severe COVID-19 infection.
Topics: COVID-19; Fibrinogen; Humans; Immunologic Tests; Retrospective Studies; SARS-CoV-2 | 2022 |
In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes.
Topics: Bone Morphogenetic Proteins; Computational Biology; COVID-19; Fibrinogen; Genomics; Growth Differentiation Factors; Humans; MicroRNAs; SARS-CoV-2 | 2023 |
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation.
Topics: COVID-19; Critical Illness; Extracellular Space; Fibrin; Fibrinogen; Hemostatics; Humans; Inflammation; Thrombosis; Vimentin | 2023 |
Characteristics of Products of Fibrinogen Origin in the Presence of Anti- SARS-CoV-2 IgG in the Bloodstream.
Topics: Antibodies, Viral; COVID-19; Fibrinogen; Humans; Immunoglobulin G; SARS-CoV-2 | 2023 |
Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Fibrinogen; Humans; Retrospective Studies; Thrombelastography; Thrombophilia | 2023 |
Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease.
Topics: C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; COVID-19; Exercise; Fibrinogen; Galectin 3; Humans; Inflammation; Insulin; Insulin Resistance; Leptin; Pandemics; Risk Factors | 2023 |
The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease.
Topics: Comorbidity; COVID-19; Fibrinogen; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Patient Acuity; Thrombosis | 2023 |
[Clinical features of severe acute respiratory syndrome coronavirus 2 Omicron variant infection in children: an analysis of 201 cases].
Topics: Asymptomatic Infections; Child; COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Interleukin-6; Nucleic Acids; Retrospective Studies; SARS-CoV-2 | 2023 |
Colitis as the Main Presentation of COVID-19: A Case Report.
Topics: Adult; Anosmia; Clostridioides difficile; Colic; Colitis; Cough; COVID-19; COVID-19 Testing; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; SARS-CoV-2 | 2023 |
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19.
Topics: Adult; Child; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; SARS-CoV-2 | 2023 |
Evaluation of the relationship between TAFI level and prognosis in COVID-19 patients.
Topics: Biomarkers; C-Reactive Protein; COVID-19; Fibrinogen; Humans; Prognosis; Thrombin | 2023 |
Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population.
Topics: Biomarkers; C-Reactive Protein; COVID-19; Fibrinogen; Hemostatics; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Polymorphism, Single Nucleotide; Retrospective Studies; Thromboinflammation | 2023 |
Significance of 1,25-Dihydroxyvitamin D
Topics: Calcitriol; COVID-19; Fibrinogen; Hemostatics; Humans; Pandemics; Peritoneal Dialysis; SARS-CoV-2 | 2023 |
Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
Topics: COVID-19; Fibrin; Fibrinogen; Hemostatics; Humans; Ivermectin; Molecular Docking Simulation; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Thrombosis | 2023 |
The usability of neopterin in determining disease course in COVID-19.
Topics: Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrinogen; Humans; Lactate Dehydrogenases; Male; Neopterin; Procalcitonin; Troponin | 2023 |
Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
Topics: Amyloid; Amyloidogenic Proteins; Autoimmunity; COVID-19; Fibrinogen; Humans; Post-Acute COVID-19 Syndrome; Prions; Thrombosis | 2023 |
The TIGIT
Topics: Bacteremia; COVID-19; Cross Infection; Fibrinogen; HMGB1 Protein; Humans; Receptors, Immunologic; Respiration, Artificial; T-Lymphocytes, Regulatory | 2023 |
Association of inactivated COVID-19 vaccination with maternal coagulation function in early pregnancy.
Topics: China; COVID-19; COVID-19 Vaccines; Female; Fibrinogen; Humans; Pregnancy; Retrospective Studies; Vaccination | 2023 |
THE ROLE OF THROMBOSIS RISK SCALES LIKE PROGRESSION PREDICTORS OF COVID-19-ASSOCIATED PNEUMONIA.
Topics: Blood Coagulation; COVID-19; Fibrinogen; Humans; Pneumonia; Thrombosis | 2023 |
The role of IL-6, ferritin, and coagulopathy in Covid-19 clinical progression.
Topics: Blood Coagulation Disorders; COVID-19; Disease Progression; Ferritins; Fibrinogen; Humans; Interleukin-6; Prospective Studies; SARS-CoV-2 | 2022 |
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Topics: Adult; Anticoagulants; Betacoronavirus; Biomarkers; Blood Coagulation; Blood Coagulation Tests; China; Coronavirus Infections; COVID-19; Disease Outbreaks; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Topics: Adult; Aged; Area Under Curve; Betacoronavirus; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Thrombin Time | 2020 |
[Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19)].
Topics: Betacoronavirus; Blood Cell Count; C-Reactive Protein; China; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Family Health; Fever; Fibrinogen; Humans; L-Lactate Dehydrogenase; Muscle Weakness; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tomography, X-Ray Computed; Travel | 2020 |
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Topics: Aged; Anticoagulants; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Testing; Disseminated Intravascular Coagulation; Drug Monitoring; Drug Tolerance; Factor VIII; Factor Xa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2 | 2020 |
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Topics: Acute Disease; Aged; Area Under Curve; Betacoronavirus; Blood Coagulation; Blood Coagulation Tests; Coronavirus Infections; COVID-19; Critical Care; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intensive Care Units; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prognosis; Respiration Disorders; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome | 2020 |
Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.
Topics: Aged; Anticoagulants; Betacoronavirus; Biomarkers; Body Mass Index; C-Reactive Protein; Catheterization, Central Venous; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Female; Fibrinogen; Health Services Needs and Demand; Humans; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Ultrasonography; Venous Thromboembolism | 2020 |
Falsely Low Fibrinogen Levels in COVID-19 Patients on Direct Thrombin Inhibitors.
Topics: Antithrombins; Betacoronavirus; Coronavirus Infections; COVID-19; Fibrinogen; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Thrombin | 2020 |
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
Topics: Arterial Occlusive Diseases; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Decision Support Techniques; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Host-Pathogen Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Organ Dysfunction Scores; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Thromboembolism; Venous Thrombosis | 2020 |
Prognosis of COVID-19: Changes in laboratory parameters.
Topics: Adult; Aged; beta-Thalassemia; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronavirus Infections; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Greece; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Prognosis; Retrospective Studies; Risk Factors | 2020 |
Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antithrombins; Betacoronavirus; C-Reactive Protein; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; Diabetes Mellitus; Dyslipidemias; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Obesity; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Protein C; Prothrombin Time; Renal Dialysis; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Fibrinogen; Glycogen Storage Disease Type IV; Hepatitis; Hepatitis B, Chronic; Humans; Inclusion Bodies; Lafora Disease; Liver; Liver Function Tests; Male; Middle Aged; Pandemics; Patient Care Management; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Treatment Outcome | 2020 |
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
Topics: Acute Disease; Acute-Phase Proteins; Betacoronavirus; Biomarkers; Blood Platelets; Coronavirus Infections; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Models, Cardiovascular; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2; Thrombophilia; Thrombosis; von Willebrand Factor | 2020 |
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Blood Coagulation Disorders; China; Coronavirus Infections; COVID-19; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prognosis; Prothrombin Time; SARS-CoV-2; Thrombin Time; Tomography, X-Ray Computed | 2020 |
Late Coronary Stent Thrombosis in a Patient With Coronavirus Disease 2019.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Angiography; Coronary Thrombosis; COVID-19; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; L-Lactate Dehydrogenase; Male; ST Elevation Myocardial Infarction; Tomography, Optical Coherence | 2020 |
Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.
Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Blood Component Transfusion; Coronavirus Infections; COVID-19; Critical Care; Databases, Factual; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; London; Male; Middle Aged; Pandemics; Plasma; Platelet Transfusion; Pneumonia, Viral; Procedures and Techniques Utilization; SARS-CoV-2 | 2020 |
Analysis of hematological indexes of COVID-19 patients from fever clinics in Suzhou, China.
Topics: Adult; Blood Cell Count; C-Reactive Protein; China; COVID-19; Female; Fever; Fibrinogen; Humans; Lymphocytes; Lymphopenia; Male; Middle Aged; Monocytes; Neutrophils; Pandemics | 2020 |
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
Topics: Biomarkers; Cohort Studies; Coronavirus Infections; COVID-19; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Male; Pandemics; Pneumonia, Viral; Risk Assessment; Sampling Studies; Severe Acute Respiratory Syndrome; Survival Rate; United Kingdom; Venous Thromboembolism; von Willebrand Factor | 2020 |
Analysis of prediction and early warning indexes of patients with COVID-19.
Topics: Adult; Bilirubin; Biomarkers; Case-Control Studies; COVID-19; Critical Illness; Early Diagnosis; Female; Fibrinogen; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Retrospective Studies; SARS-CoV-2 | 2020 |
VTE in ICU Patients With COVID-19.
Topics: Adult; Aged; Anticoagulants; Betacoronavirus; C-Reactive Protein; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Incidence; Intensive Care Units; L-Lactate Dehydrogenase; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin Time; Pulmonary Embolism; SARS-CoV-2; Severity of Illness Index; Ultrasonography; Venous Thromboembolism; Venous Thrombosis | 2020 |
Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
Topics: Amino Acid Motifs; Bacterial Proteins; Coronavirus Nucleocapsid Proteins; COVID-19; Fibrinogen; Host-Pathogen Interactions; Humans; Immune System; Models, Theoretical; Peptides; Phosphoproteins; Protein Binding; Protein Domains; SARS-CoV-2; Staphylococcus aureus; von Willebrand Factor | 2020 |
Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
Topics: Adult; Betacoronavirus; Blood Coagulation Disorders; Cohort Studies; Coronavirus Infections; COVID-19; Female; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome; von Willebrand Factor | 2020 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart-Assist Devices; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Retroperitoneal Space; Thrombocytopenia; Thrombosis | 2020 |
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Comorbidity; Coronavirus Infections; COVID-19; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Procalcitonin; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Rate; Tomography, X-Ray Computed | 2020 |
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Topics: Aged; Betacoronavirus; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Progression; Female; Fibrinogen; Host Microbial Interactions; Humans; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Time Factors | 2020 |
Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: a case report.
Topics: Adult; Antifibrinolytic Agents; Betacoronavirus; Blood Coagulation Disorders; Blood Loss, Surgical; Breech Presentation; C-Reactive Protein; Cautery; Cesarean Section; Coronavirus Infections; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis, Surgical; Humans; International Normalized Ratio; Methylergonovine; Oligohydramnios; Oxytocics; Oxytocin; Pandemics; Platelet Count; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prothrombin Time; SARS-CoV-2; Tranexamic Acid; Uterine Inertia | 2020 |
Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
Topics: Adult; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; Diarrhea; False Negative Reactions; Feces; Female; Fibrinogen; Humans; Lung; Male; Middle Aged; Oropharynx; Pandemics; Pneumonia, Viral; Prognosis; Real-Time Polymerase Chain Reaction; RNA Stability; RNA, Viral; SARS-CoV-2; Symptom Assessment; Viral Load; Virus Shedding | 2020 |
Therapeutic plasma exchange in a critically ill Covid-19 patient.
Topics: Aged; Albumins; C-Reactive Protein; Combined Modality Therapy; COVID-19; Critical Illness; Cytokine Release Syndrome; Fibrinogen; Humans; Interleukin-6; Male; Oxygen; Oxygen Inhalation Therapy; Plasma Exchange; Pneumonia, Ventilator-Associated; Respiration, Artificial; Respiratory Distress Syndrome; Salvage Therapy; SARS-CoV-2; Solutions | 2021 |
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Topics: Adult; Aged; Betacoronavirus; Blood Cell Count; Comorbidity; Coronavirus Infections; COVID-19; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Pandemics; Patient Admission; Plasminogen; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; COVID-19; Critical Illness; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Pandemics; Platelet Count; Retrospective Studies; SARS-CoV-2; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Young Adult | 2021 |
COVID-19 and Hypercoagulability.
Topics: Anticoagulants; Betacoronavirus; Biomarkers; Blood Platelets; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis; von Willebrand Factor | 2020 |
Lupus anticoagulant in patients with COVID-19.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Epidemics; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; SARS-CoV-2 | 2021 |
Routine haematology parameters in COVID-19 patients and clinical outcome: A Belgian single-centre study.
Topics: Aged; Belgium; Betacoronavirus; Blood Cell Count; Blood Coagulation Tests; Coronavirus Infections; COVID-19; Diagnostic Tests, Routine; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2020 |
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate.
Topics: Aged; Anticoagulants; Benzamidines; COVID-19; COVID-19 Drug Treatment; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guanidines; Humans; Male; Middle Aged; Retrospective Studies | 2021 |
Multiple organ injury on admission predicts in-hospital mortality in patients with COVID-19.
Topics: Aged; C-Reactive Protein; COVID-19; Female; Fibrinogen; Hospital Mortality; Hospitalization; Humans; Incidence; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Multiple Organ Failure; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2 | 2021 |
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Topics: Aged; Area Under Curve; Betacoronavirus; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Body Mass Index; Coronavirus Infections; COVID-19; Critical Illness; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Protein C; Protein S; ROC Curve; SARS-CoV-2; Venous Thromboembolism | 2020 |
Clinical characteristics and laboratory indicator analysis of 67 COVID-19 pneumonia patients in Suzhou, China.
Topics: Adult; Betacoronavirus; China; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; Female; Fibrinogen; Hospitalization; Humans; Lung; Lymphocyte Count; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity | 2020 |
COVID-19 impact on consecutive neurological patients admitted to the emergency department.
Topics: Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; C-Reactive Protein; Case-Control Studies; Comorbidity; COVID-19; Emergency Service, Hospital; Female; Fibrinogen; Hospitalization; Humans; Italy; Male; Middle Aged; Nervous System Diseases; SARS-CoV-2 | 2021 |
Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; L-Lactate Dehydrogenase; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Procalcitonin; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Sex Factors; T-Lymphocytes | 2021 |
Clinical Features of 154 COVID-19 Patients and the Parameters for the Effective Detection of Pneumonia at the Time of the Initial Diagnosis in Japan.
Topics: Adult; Age Factors; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Female; Fever; Fibrinogen; Humans; Japan; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Oximetry; Platelet Count; Retrospective Studies; Risk Factors; SARS-CoV-2; Tachycardia | 2021 |
Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
Topics: Aged; Antibodies, Monoclonal, Humanized; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Female; Fibrinogen; Hospitalization; Humans; Immunomodulation; Inflammation; Inflammation Mediators; Male; Middle Aged; Receptors, Interleukin-6; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables.
Topics: Adolescent; Adult; Amyloidogenic Proteins; Child; Child, Preschool; COVID-19; Diagnosis, Differential; Eosinophilia; Female; Fibrinogen; Humans; Influenza, Human; L-Lactate Dehydrogenase; Leukocytosis; Lymphocyte Count; Male; Middle Aged; Monocytes; Neutrophils; Pneumonia, Bacterial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Young Adult | 2021 |
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.
Topics: alpha-2-Antiplasmin; COVID-19; Critical Care; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; SARS-CoV-2 | 2021 |
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; International Normalized Ratio; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Respiratory Distress Syndrome; SARS-CoV-2; Thrombelastography; Treatment Outcome | 2020 |
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
Topics: ADAMTS13 Protein; Aged; Biomarkers; Blood Cell Count; C-Reactive Protein; Case-Control Studies; COVID-19; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pneumonia; SARS-CoV-2; Thrombophilia; von Willebrand Factor | 2021 |
Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Comorbidity; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Interleukin-6; Male; Middle Aged; Prognosis; Severity of Illness Index; Thrombelastography; Thromboembolism; Thrombophilia; Young Adult | 2021 |
Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.
Topics: Adult; C-Reactive Protein; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Thrombelastography; Thrombophilia | 2021 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Topics: Aged; Anticoagulants; Biomarkers; Blood Coagulation; COVID-19; Critical Illness; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2021 |
Clot waveform of APTT has abnormal patterns in subjects with COVID-19.
Topics: Aged; Blood Coagulation; Blood Coagulation Tests; COVID-19; Female; Fibrinogen; Humans; Male; Middle Aged; Organometallic Compounds; Triazoles | 2021 |
Vitamin D and disease severity in coronavirus disease 19 (COVID-19).
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Comorbidity; COVID-19; Disease Susceptibility; Dyspnea; Female; Fibrinogen; Humans; Italy; Length of Stay; Male; Middle Aged; Oxygen; Partial Pressure; Prevalence; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Vitamin D; Vitamin D Deficiency | 2021 |
Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ.
Topics: Aged; Cell Line; Chemokine CCL5; COVID-19; Exosomes; Female; Fibrinogen; Hepatocytes; Humans; Inflammation; Interleukin-6; Male; Mass Spectrometry; Microscopy, Electron, Transmission; Middle Aged; NF-kappa B; Protein Interaction Maps; Proteome; Tenascin; Tumor Necrosis Factor-alpha | 2021 |
Downregulation of type III interferons in patients with severe COVID-19.
Topics: Adult; Aged; C-Reactive Protein; Chemokines; COVID-19; Down-Regulation; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interferon Lambda; Interferons; Interleukins; L-Lactate Dehydrogenase; Male; Middle Aged; Mucin-1; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Protein D; SARS-CoV-2; Severity of Illness Index | 2021 |
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation.
Topics: Adult; C-Reactive Protein; Computed Tomography Angiography; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Intracranial Hemorrhages; London; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; State Medicine; Tertiary Care Centers; Ultrasonography, Doppler; Venous Thromboembolism; Venous Thrombosis | 2021 |
Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area.
Topics: Biomarkers; COVID-19; Diagnosis, Differential; Female; Fibrinogen; Humans; Japan; Leukocyte Count; Male; Olfaction Disorders; Predictive Value of Tests; Prevalence; Taste Disorders; Tomography, X-Ray Computed | 2021 |
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
Topics: ADAMTS13 Protein; Aged; Ambulatory Care; Biomarkers; Correlation of Data; COVID-19; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Assessment; SARS-CoV-2; Severity of Illness Index; Spain; Thrombophilia; von Willebrand Factor | 2021 |
Hematologic adaptation to mask-wearing among pregnant women and obstetrical outcome during the coronavirus disease 2019 pandemic.
Topics: Adult; Blood Platelets; Cesarean Section; Cohort Studies; COVID-19; Female; Fibrinogen; Hemoglobins; Hospitalization; Humans; Masks; Pandemics; Pregnancy; Pregnant Women; SARS-CoV-2; Term Birth | 2021 |
Predictive value of D-dimer/albumin ratio and fibrinogen/albumin ratio for in-hospital mortality in patients with COVID-19.
Topics: Albumins; Biomarkers; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2 | 2021 |
The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19.
Topics: Albumins; COVID-19; Fibrinogen; Humans; Prognosis; Retrospective Studies; SARS-CoV-2 | 2021 |
Analysis of laboratory blood parameter results for patients diagnosed with COVID-19, from all ethnic group populations: A single centre study.
Topics: Adult; Aged; Aged, 80 and over; COVID-19; Ethnicity; Female; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Serum Albumin, Human; Urea | 2021 |
Cytokine storm in severe COVID-19 pneumonia.
Topics: Aged; Alanine Transaminase; Anemia; Aspartate Aminotransferases; Biomarkers; COVID-19; Cytokine Release Syndrome; Diagnosis, Differential; Disease Progression; Female; Fibrinogen; Humans; Hyperferritinemia; Intensive Care Units; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Lymphopenia; Macrophage Activation Syndrome; Male; Middle Aged; Procalcitonin; Retrospective Studies; SARS-CoV-2; Thrombocytopenia; Triglycerides; Troponin | 2021 |
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.
Topics: Adult; Blood Coagulation Disorders; COVID-19; Endothelial Cells; Fibrinogen; Humans; Interleukin-6; Janus Kinase 1; Liver Diseases; Nitriles; Pyrazoles; Pyrimidines; Retrospective Studies; SARS-CoV-2; Signal Transduction; STAT3 Transcription Factor; von Willebrand Factor | 2021 |
Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Altitude; China; Cough; COVID-19; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Lymphocytes; Male; Middle Aged; Neutrophils; Retrospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Young Adult | 2021 |
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cell Size; COVID-19; Female; Ferritins; Fibrinogen; Humans; Inflammation; Italy; Longitudinal Studies; Male; Middle Aged; Monocytes; Patient Admission; Pilot Projects; Prognosis; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Young Adult | 2021 |
Brief psychotic disorder in COVID-19 patient with no history of mental illness.
Topics: Acute Disease; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Indonesia; Male; Middle Aged; Psychotic Disorders; Radiography; Thorax | 2021 |
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
Topics: C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Retrospective Studies; Thrombophilia; Thrombosis | 2022 |
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
Topics: Adult; Aged; Amyloid; Blood Platelets; Complement C3; COVID-19; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lung; Male; Microfluidic Analytical Techniques; Middle Aged; Prothrombin; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thrombosis; Trypsin | 2021 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Black or African American; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Testing; Diabetes Mellitus; Early Diagnosis; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Hospitalization; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Obesity; Organ Dysfunction Scores; Prognosis; Prospective Studies; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome; White People | 2021 |
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis | 2021 |